The Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor ZD1839 (Iressa) Suppresses c-Src and Pak1 Pathways and Invasiveness of Human Cancer Cells

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Kinase Inhibitor ◽

Human Cancer ◽

Growth Factor Receptor ◽

Human Cancer Cells ◽

Regulation of Epidermal Growth Factor Receptor Signaling in Human Cancer Cells by MicroRNA-7

Journal of Biological Chemistry ◽

10.1074/jbc.m804280200 ◽

2008 ◽

Vol 284 (9) ◽

pp. 5731-5741 ◽

Cited By ~ 300

Author(s):

Rebecca J. Webster ◽

Keith M. Giles ◽

Karina J. Price ◽

Priscilla M. Zhang ◽

John S. Mattick ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Human Cancer ◽

Growth Factor Receptor ◽

Receptor Signaling ◽

Human Cancer Cells ◽

Epidermal Growth ◽

Growth Factor Receptor Signaling

The epidermal growth factor receptor tyrosine kinase inhibitor gefitinib sensitizes colon cancer cells to irinotecan

Anti-Cancer Drugs ◽

10.1097/00001813-200511000-00009 ◽

2005 ◽

Vol 16 (10) ◽

pp. 1099-1108 ◽

Cited By ~ 20

Author(s):

Ada Henrike Braun ◽

Katrin Stark ◽

Olaf Dirsch ◽

Ralf Axel Hilger ◽

Siegfried Seeber ◽

...

Keyword(s):

Colon Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Colon Cancer Cells ◽

Enhancement of Radiosensitivity in Head and Neck Cancer Cells by ZD1839 (???IRESSA???), A Selective Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000091356.25759.69 ◽

2003 ◽

Vol 26 (5) ◽

pp. e150-e156 ◽

Cited By ~ 13

Author(s):

Satoru Shintani ◽

Akihisa Kiyota ◽

Mariko Mihara ◽

Tomoki Sumida ◽

Hiroaki Kayahara ◽

...

Keyword(s):

Head And Neck Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Cancer Cells ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Scheduling of paclitaxel and gefitinib to inhibit repopulation for optimal treatment of human cancer cells and xenografts that overexpress the epidermal growth factor receptor

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2229-3 ◽

2013 ◽

Vol 72 (3) ◽

pp. 585-595 ◽

Cited By ~ 3

Author(s):

Andrea S. Fung ◽

Man Yu ◽

Qian Jess Ye ◽

Ian F. Tannock

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Human Cancer ◽

Growth Factor Receptor ◽

Optimal Treatment ◽

Human Cancer Cells ◽

797. Oncolytic Adenovirus Induces Autophagic Cell Death through an E2F1-micro RNA-7-Epidermal Growth Factor Receptor Axis in Human Cancer Cells

Molecular Therapy ◽

10.1016/s1525-0016(16)37370-1 ◽

2011 ◽

Vol 19 ◽

pp. S304-S305

Keyword(s):

Cell Death ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Human Cancer ◽

Growth Factor Receptor ◽

Micro Rna ◽

Human Cancer Cells ◽

Lung cancer cells survive epidermal growth factor receptor tyrosine kinase inhibitor exposure through upregulation of cholesterol synthesis

FASEB BioAdvances ◽

10.1096/fba.2019-00081 ◽

2019 ◽

Vol 2 (2) ◽

pp. 90-105 ◽

Cited By ~ 1

Author(s):

Mark C. Howell ◽

Ryan Green ◽

Roukiah Khalil ◽

Elspeth Foran ◽

Waise Quarni ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Cholesterol Synthesis ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer Cells

Frontiers in Pharmacology ◽

10.3389/fphar.2018.01097 ◽

2018 ◽

Vol 9 ◽

Cited By ~ 18

Author(s):

Wei Zhang ◽

Ying-Fang Fan ◽

Chao-Yun Cai ◽

Jing-Quan Wang ◽

Qiu-Xu Teng ◽

...

Keyword(s):

Multidrug Resistance ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Tyrosine Kinase Inhibitor ◽

Cancer Cells ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

AplidinTMInduces Apoptosis in Human Cancer Cells via Glutathione Depletion and Sustained Activation of the Epidermal Growth Factor Receptor, Src, JNK, and p38 MAPK

Journal of Biological Chemistry ◽

10.1074/jbc.m201010200 ◽

2002 ◽

Vol 278 (1) ◽

pp. 241-250 ◽

Cited By ~ 105

Author(s):

Ana Cuadrado ◽

Luis F. Garcı́a-Fernández ◽

Laura González ◽

Yajaira Suárez ◽

Alejandro Losada ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Human Cancer ◽

Growth Factor Receptor ◽

Glutathione Depletion ◽

Human Cancer Cells ◽

Epidermal Growth ◽

Sustained Activation

Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer Cells

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-08-2068 ◽

2009 ◽

Vol 15 (5) ◽

pp. 1585-1592 ◽

Cited By ~ 70

Author(s):

Sergio Benavente ◽

Shyhmin Huang ◽

Eric A. Armstrong ◽

Alexander Chi ◽

Kun-Tai Hsu ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Human Cancer ◽

Acquired Resistance ◽

Growth Factor Receptor ◽

Human Cancer Cells ◽

HER2 Overexpression Increases Sensitivity to Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, through Inhibition of HER2/HER3 Heterodimer Formation in Lung Cancer Cells

Cancer Research ◽

10.1158/0008-5472.can-04-2748 ◽

2005 ◽

Vol 65 (10) ◽

pp. 4253-4260 ◽

Cited By ~ 84

Author(s):

Akira Hirata ◽

Fumihito Hosoi ◽

Miho Miyagawa ◽

Shu-ichi Ueda ◽

Seiji Naito ◽

...

Keyword(s):

Lung Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Cancer Cells ◽

Kinase Inhibitor ◽

Growth Factor Receptor ◽

Her2 Overexpression ◽